Table 3.
AUC (95% CI) |
TPFFPF5% | ||
---|---|---|---|
Difference | |||
Age | 0.63 (0.60–0.65) | -0.05 | 0.08 (0.06–0.10) |
Sex | 0.61 (0.59–0.64) | -0.07 | –a |
Age and sex | 0.68 (0.66–0.70) | Reference | 0.09 (0.07–0.13) |
Traditional risk factors | |||
– Systolic blood pressurea | 0.65 (0.62–0.67) | -0.03 | 0.10 (0.08–0.14) |
– Diastolic blood pressure | 0.60 (0.58–0.62) | -0.08 | 0.08 (0.05–0.10) |
– Hypertension arterial | 0.58 (0.56–0.61) | -0.10 | – |
– Glucose | 0.61 (0.59–0.64) | -0.07 | 0.14 (0.10–0.17) |
– Diabetes | 0.57 (0.54–0.59) | -0.11 | – |
– Total cholesterol | 0.57 (0.54–0.59) | -0.11 | 0.06 (0.04–0.08) |
– HDL cholesterol | 0.64 (0.61–0.66) | -0.04 | 0.02 (0.01–0.04) |
– LDL cholesterol | 0.58 (0.55–0.61) | -0.10 | 0.07 (0.04–0.09) |
– LDL/HDL ratio | 0.65 (0.63–0.68) | -0.03 | 0.11 (0.09–0.17) |
– Triglycerides | 0.61 (0.58–0.63) | -0.07 | 0.09 (0.07–0.12) |
– Body Mass Index (BMI) | 0.59 (0.56–0.61) | -0.09 | 0.07 (0.05–0.10) |
– Cigarette smoking | 0.58 (0.55–0.60) | -0.14 | – |
Biomarkers | |||
– CRP | 0.61 (0.58–0.63) | -0.07 | 0.09 (0.06–0.11) |
– Cystatin C | 0.62 (0.59–0.65) | -0.06 | 0.11 (0.08–0.14) |
– Lp-PLA2 activity | 0.61 (0.58–0.64) | -0.07 | 0.11 (0.07–0.14) |
– N-BNP | 0.54 (0.51–0.57) | -0.14 | 0.10 (0.07–0.12) |
– N-BNP (309 pg/mL) | 0.52 (0.49–0.55) | -0.16 | – |
Combinations | |||
– Traditional risk factors (RF) | 0.71 (0.69–0.74) | 0.03 | 0.19 (0.16–0.23) |
– Biomarkers (BM) | 0.67 (0.64–0.69) | -0.01 | 0.13 (0.10–0.17) |
– RF and BM | 0.74 (0.71–0.76) | 0.06 | 0.21 (0.17–0.26) |
– Age, sex and RF | 0.75 (0.73–0.77) | 0.07 | 0.22 (0.18–0.27) |
– Age, sex and BM | 0.72 (0.69–0.74) | 0.04 | 0.16 (0.11–0.20) |
– Age, sex, RF and BM | 0.77 (0.74–0.79) | 0.08 | 0.23 (0.17–0.28) |
CRP: C-Reactive Protein. LpPLA2: Lipoprotein-associated phospholipase A2. NTBNP: N-terminal B-type natriuretic peptide.
Value not calculated as the variable is dichotomous.